subscribeSubscribe
Enforcement Report - Week of February 28, 2024

Enforcement Report - Week of February 28, 2024
FDA
28 Feb 2024
Share Share
Mallinckrodt Presents New Data on TERLIVAZ for Injection at SCCM

Mallinckrodt Presents New Data on TERLIVAZ for Injection at SCCM
PR NEWSWIRE
22 Jan 2024
Share Share
Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ

Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ
PR NEWSWIRE
21 Dec 2023
Share Share
Mallinckrodt to Present Breadth of Data on TERLIVAZ (terlipressin) for Injection

Mallinckrodt to Present Breadth of Data on TERLIVAZ (terlipressin) for Injection
PR NEWSWIRE
08 Nov 2023
Share Share
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients

Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients
PR NEWSWIRE
01 Nov 2023
Share Share
Mallinckrodt to Present Data on TERLIVAZ for Injection in Patients with HRS

Mallinckrodt to Present Data on TERLIVAZ for Injection in Patients with HRS
PR NEWSWIRE
22 Oct 2023
Share Share
Mallinckrodt to Present Data on TERLIVAZ

Mallinckrodt to Present Data on TERLIVAZ
PR NEWSWIRE
15 Jun 2023
Share Share
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection
PR NEWSWIRE
01 Jun 2023
Share Share
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection
PR NEWSWIRE
08 May 2023
Share Share
2022 drug approvals: Biopharma delivered 37 new drugs

2022 drug approvals: Biopharma delivered 37 new drugs
Kevin Dunleavy FIERCE PHARMA
03 Jan 2023
Share Share